CNBX News and Press, Cannabics Pharmaceuticals Inc From 03/28/22

Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals PR Newswire TEL AVIV, Israel and BETHESDA, Md. , March 28, 2022 /PRNewswire/ --  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer relate...

CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials PR Newswire TEL AVIV , Israel and BETHESDA, Md., Nov. 4, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in...

Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago PR Newswire TEL AVIV , Israel and BETHESDA, Md., Oct. 26, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabin...

Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors PR Newswire TEL AVIV , Israel and BETHESDA, Md., Oct. 25, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer rel...

EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX PR Newswire TEL AVIV , Israel and BETHESDA, Md., Oct. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer re...

CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas PR Newswire TEL AVIV , Israel and BETHESDA, Md., Oct. 20, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of ca...

CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021 PR Newswire TEL AVIV , Israel and BETHESDA, Md., Oct. 19, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the ...

Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer PR Newswire TEL AVIV , Israel and BETHESDA, Md., Oct. 18, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in...

CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference PR Newswire TEL AVIV, Israel and BETHESDA, Md. , Oct. 14, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. ( CNBX ),&...

Cannabics Announces New Corporate Logo, New Website and New Company Presentation PR Newswire TEL AVIV , Israel and BETHESDA, Md., Sept. 30, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of can...